Literature DB >> 15372219

Diffusion MR findings in cyclosporin-A induced encephalopathy.

Kubilay Aydin1, Fuldem Donmez, Umit Tuzun, Ozenc Minareci, Tanju Atamer.   

Abstract

Cyclosporin encephalopathy is a well-known entity, which is clinically characterized by altered mental status, vision problems, focal neurological deficits and seizures. The exact pathophysiology of the cyclosporin encephalopathy has not yet been defined. We report the diffusion-weighted MR imaging and proton MR spectroscopy findings in a case of cyclosporin encephalopathy. The white-matter lesions with reversible restricted diffusion supported the hypothesis of reversible vasospasm induced by the cyclosporin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15372219     DOI: 10.1007/s00234-004-1258-3

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  4 in total

Review 1.  Cyclosporine neurotoxicity: a review.

Authors:  J M Gijtenbeek; M J van den Bent; C J Vecht
Journal:  J Neurol       Date:  1999-05       Impact factor: 4.849

2.  Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity.

Authors:  W S Bartynski; Z Zeigler; M P Spearman; L Lin; R K Shadduck; J Lister
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

3.  Diffusion weighted imaging and magnetic resonance spectroscopy in a low flow ischaemia model due to endothelin induced vasospasm.

Authors:  Z Domingo; J K Bradley; A M Blamire; K Brindle; P Styles; B Rajagopalan
Journal:  NMR Biomed       Date:  2000-05       Impact factor: 4.044

4.  Prolonged reversible vasospasm in cyclosporin A-induced encephalopathy.

Authors:  Jen-Tsun Lin; Shuu-Jiun Wang; Jong-Ling Fuh; Lian-Tsai Hsiao; Jiing-Feng Lirng; Po-Min Chen
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

  4 in total
  2 in total

Review 1.  Multiple myeloma.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2010-02-11       Impact factor: 3.909

2.  Problems monitoring response in multiple myeloma.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2005-11-23       Impact factor: 3.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.